Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause hair loss, and managing it involves counseling, diet changes, and treatments.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Three specific mutations in the LIPH gene can cause hair loss by damaging the protein's structure and function.

Cannabis may help with skin and hair health but could also increase heart and stroke risks.

Mesenchymal stem cells may effectively treat and prevent allergic skin conditions.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Severe COVID-19 increases the risk of hair loss.

Hesperidin may help reduce hair loss by protecting hair follicles.

More skin issues appeared in the emergency department during COVID-19, highlighting the need for better dermatology training and resources.

Three different methods were compared for creating Titan cells, a type of fungus cell. The OZ method made the most cells initially, but the number dropped quickly. The EB method also made a lot of cells, but the number also dropped. The AA method made fewer cells, but the number stayed steady. The methods also affected which genes were active in the cells.

Men are more at risk for severe COVID-19 due to biological differences, suggesting the need for targeted treatments.

Geranium pyrenaicum extracts show potential for cancer, antiviral, and enzyme inhibition treatments.

Hospitalized COVID-19 survivors have a higher risk of long-term symptoms and need special care.

COVID-19 affects multiple body systems, not just the lungs.

Severe hair loss may increase the risk of dying from COVID-19.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

Neuropathic pain is common in long COVID patients, especially those with depression or severe COVID-19.

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

We need safe, affordable drugs to fight coronaviruses effectively.

Damaged skin has a weakened barrier, making it more vulnerable to substances and inflammation.

Cepharanthine dry powder inhalers may effectively treat acute lung injury by reducing inflammation.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Certain immune responses may cause ongoing COVID-19 symptoms like fatigue and brain fog.

Polymeric nanoparticles could improve hair loss treatments by delivering drugs more effectively to hair follicles.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

Extracellular water levels don't indicate COVID-19 pneumonia severity.

Long-lasting symptoms like fatigue and breathlessness can persist after COVID-19, requiring ongoing medical follow-up.

Collider bias can mislead our understanding of COVID-19 risk and severity.